Y, X., W, C., J, W., H, G., F, Z., T, Z., . . . X, W. (2026). Comparison of in-field secondary cancer risk based on therapeutic proton dose between proton arc therapy and intensity-modulated proton therapy in lung cancer patients. Journal of applied clinical medical physics, 27(9), e70793. https://doi.org/10.1002/acm2.70793
Παραπομπή σε μορφή Chicago (17η εκδ.)Y, Xu, et al. "Comparison of In-field Secondary Cancer Risk Based on Therapeutic Proton Dose Between Proton Arc Therapy and Intensity-modulated Proton Therapy in Lung Cancer Patients." Journal of Applied Clinical Medical Physics 27, no. 9 (2026): e70793. https://doi.org/10.1002/acm2.70793.
Παραπομπή σε μορφή MLA (9th εκδ.)Y, Xu, et al. "Comparison of In-field Secondary Cancer Risk Based on Therapeutic Proton Dose Between Proton Arc Therapy and Intensity-modulated Proton Therapy in Lung Cancer Patients." Journal of Applied Clinical Medical Physics, vol. 27, no. 9, 2026, p. e70793, https://doi.org/10.1002/acm2.70793.